All News
Filter News
Found 149 articles
-
Stealth Biotherapeutics Initiates Phase 2 Study Of Elamipretide In Patients Hospitalized With Congestive Heart Failure
10/25/2016
-
Stealth Biotherapeutics Reports Elamipretide Improved Skeletal Muscle Bioenergetics In The Elderly
9/19/2016
-
Stealth Biotherapeutics Initiates Phase 2 Study Of Elamipretide In Primary Mitochondrial Disease
9/12/2016
-
Stealth Biotherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide For The Treatment Of Heart Failure
6/27/2016
-
Stealth Biotherapeutics Reports Positive Elamipretide Data In First-Of-Its-Kind Primary Mitochondrial Myopathy Trial
6/17/2016
-
Stealth Biotherapeutics Reports Positive Results For Primary Mitochondrial Myopathy Trial
6/6/2016
-
Stealth Biotherapeutics Initiates Phase 2 Study Of Elamipretide In Leber's Hereditary Optic Neuropathy
6/1/2016
-
Stealth Biotherapeutics Announces Presentation Of Elamipretide Data At American College of Cardiology
4/4/2016
-
Stealth Biotherapeutics Initiates Phase 2 Clinical Study Of Elamipretide In Fuchs' Corneal Endothelial Dystrophy
3/8/2016